LGND - Ligand Pharmaceuticals Incorporated

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts4454
Avg. Estimate0.540.683.83.88
Low Estimate0.380.673.23.68
High Estimate0.620.76.084
Year Ago EPS2.591.327.153.8
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts5555
Avg. Estimate21.29M25.12M118.8M127.31M
Low Estimate17.28M24.4M117.7M124.77M
High Estimate23.94M26.22M121.33M129.4M
Year Ago Sales90.04MN/A251.45M118.8M
Sales Growth (year/est)-76.40%N/A-52.80%7.20%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.2.341.031.221.02
EPS Actual2.591.321.71.16
Difference0.250.290.480.14
Surprise %10.70%28.20%39.30%13.70%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate0.540.683.83.88
7 Days Ago0.540.683.83.88
30 Days Ago0.560.73.923.88
60 Days Ago0.630.774.163.85
90 Days Ago1.211.355.354
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days2221
Up Last 30 Days2221
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days111N/A
Growth EstimatesLGNDIndustrySectorS&P 500
Current Qtr.-79.20%N/AN/A0.02
Next Qtr.-48.50%N/AN/A0.04
Current Year-46.90%N/AN/A0.05
Next Year2.10%N/AN/A0.10
Next 5 Years (per annum)25.00%N/AN/A0.10
Past 5 Years (per annum)40.29%N/AN/AN/A